|
Table of Content - Volume 10 Issue 2 - May 2018
A comparative study of efficacy of single dose of intravenous ferric carboxymaltose over oral iron therapy in severe iron deficiency Anemia
Makarand Balwant Mane1*, Priyanka Makarand Mane2,Akshay Shirshat3,Tejas Uttamrao Bhosale4
1Associate Professor, 3,4Senior Resident, Department of Medicine} {2Assistant Professor, Department of Microbiology} Krishna Hospital, P B Road, Malkapur Karad, Satara, Malkapur, INDIA.
Email: makarand.mane@gmail.com
REFERENCES
- S. Killip, J. M. Bennett, and M. D. Chambers, “Iron deficiency anemia,” American Family Physician, vol. 75, no. 5, pp. 671– 678, 2007
- J. Umbreit, “Iron deficiency: a concise review,” American Journal of Hematology, vol. 78, no. 3, pp. 225–231, 2005.
- Ministry of Health and Family Welfare, Government of India. Guidelines for control of Iron deficiency anaemia. New Delhi: Ministry of Health and Family Welfare, Government of India; 2013. Available at: http://www.unicef.org/india/10._National_Iron_Plus_Initiative_Guidelines_for_Control_of_IDA.pdf. Accessed 18 January 2018.
- Killip, S., Bennett, J. and Chambers, M. (2007) Iron deficiency anemia. Am Fam Physician 75: 671–678.
- Salve MP, Inamdar SA, Bhaumik DK, Patil AR. Single dose intravenous carboxymaltose versus oral iron therapy in the treatment of anaemia in postpartum patients in a rural area. Journal of Evidence Based Medicine and Healthcare. 2017 Jan 1;4(14):842-7.
- Naqash A, Ara R, Bader GN. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials. BMC women's health. 2018 Dec;18(1):6.
|
|